nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A4—Rivastigmine—Alzheimer's disease	0.0837	0.432	CbGbCtD
Zaleplon—CYP3A4—Donepezil—Alzheimer's disease	0.0669	0.345	CbGbCtD
Zaleplon—CYP3A4—Galantamine—Alzheimer's disease	0.0431	0.223	CbGbCtD
Zaleplon—TSPO—blood vessel—Alzheimer's disease	0.00477	0.064	CbGeAlD
Zaleplon—GABRG2—forebrain—Alzheimer's disease	0.00298	0.0399	CbGeAlD
Zaleplon—GABRB2—forebrain—Alzheimer's disease	0.00298	0.0399	CbGeAlD
Zaleplon—TSPO—embryo—Alzheimer's disease	0.00285	0.0382	CbGeAlD
Zaleplon—GABRG2—telencephalon—Alzheimer's disease	0.00274	0.0367	CbGeAlD
Zaleplon—GABRB2—telencephalon—Alzheimer's disease	0.00274	0.0367	CbGeAlD
Zaleplon—GABRA2—forebrain—Alzheimer's disease	0.00272	0.0365	CbGeAlD
Zaleplon—GABRA1—forebrain—Alzheimer's disease	0.00263	0.0352	CbGeAlD
Zaleplon—TSPO—forebrain—Alzheimer's disease	0.00252	0.0338	CbGeAlD
Zaleplon—GABRA2—telencephalon—Alzheimer's disease	0.0025	0.0335	CbGeAlD
Zaleplon—GABRA1—telencephalon—Alzheimer's disease	0.00242	0.0324	CbGeAlD
Zaleplon—TSPO—telencephalon—Alzheimer's disease	0.00232	0.031	CbGeAlD
Zaleplon—GABRB3—forebrain—Alzheimer's disease	0.00229	0.0307	CbGeAlD
Zaleplon—GABRB3—telencephalon—Alzheimer's disease	0.0021	0.0282	CbGeAlD
Zaleplon—GABRB2—nervous system—Alzheimer's disease	0.00162	0.0217	CbGeAlD
Zaleplon—GABRG2—nervous system—Alzheimer's disease	0.00162	0.0217	CbGeAlD
Zaleplon—GABRG2—central nervous system—Alzheimer's disease	0.00156	0.0209	CbGeAlD
Zaleplon—GABRB2—central nervous system—Alzheimer's disease	0.00156	0.0209	CbGeAlD
Zaleplon—GABRG2—cerebellum—Alzheimer's disease	0.00152	0.0204	CbGeAlD
Zaleplon—GABRB2—cerebellum—Alzheimer's disease	0.00152	0.0204	CbGeAlD
Zaleplon—AOX1—cerebellum—Alzheimer's disease	0.00151	0.0202	CbGeAlD
Zaleplon—GABRA2—nervous system—Alzheimer's disease	0.00148	0.0198	CbGeAlD
Zaleplon—GABRA1—nervous system—Alzheimer's disease	0.00143	0.0191	CbGeAlD
Zaleplon—GABRA2—central nervous system—Alzheimer's disease	0.00142	0.0191	CbGeAlD
Zaleplon—GABRA2—cerebellum—Alzheimer's disease	0.00139	0.0186	CbGeAlD
Zaleplon—GABRA1—central nervous system—Alzheimer's disease	0.00137	0.0184	CbGeAlD
Zaleplon—TSPO—nervous system—Alzheimer's disease	0.00137	0.0183	CbGeAlD
Zaleplon—GABRA1—cerebellum—Alzheimer's disease	0.00134	0.018	CbGeAlD
Zaleplon—TSPO—central nervous system—Alzheimer's disease	0.00132	0.0176	CbGeAlD
Zaleplon—TSPO—cerebellum—Alzheimer's disease	0.00129	0.0172	CbGeAlD
Zaleplon—GABRB3—nervous system—Alzheimer's disease	0.00124	0.0166	CbGeAlD
Zaleplon—GABRB2—brain—Alzheimer's disease	0.00124	0.0166	CbGeAlD
Zaleplon—GABRG2—brain—Alzheimer's disease	0.00124	0.0166	CbGeAlD
Zaleplon—AOX1—brain—Alzheimer's disease	0.00122	0.0164	CbGeAlD
Zaleplon—GABRB3—central nervous system—Alzheimer's disease	0.0012	0.016	CbGeAlD
Zaleplon—GABRB3—cerebellum—Alzheimer's disease	0.00117	0.0157	CbGeAlD
Zaleplon—GABRA2—brain—Alzheimer's disease	0.00113	0.0151	CbGeAlD
Zaleplon—GABRA1—brain—Alzheimer's disease	0.00109	0.0146	CbGeAlD
Zaleplon—TSPO—brain—Alzheimer's disease	0.00105	0.014	CbGeAlD
Zaleplon—GABRB3—brain—Alzheimer's disease	0.000949	0.0127	CbGeAlD
Zaleplon—Anaemia—Galantamine—Alzheimer's disease	0.000677	0.00112	CcSEcCtD
Zaleplon—Dysuria—Rivastigmine—Alzheimer's disease	0.000676	0.00112	CcSEcCtD
Zaleplon—Weight increased—Memantine—Alzheimer's disease	0.000673	0.00111	CcSEcCtD
Zaleplon—Agitation—Galantamine—Alzheimer's disease	0.000673	0.00111	CcSEcCtD
Zaleplon—Weight decreased—Memantine—Alzheimer's disease	0.000669	0.00111	CcSEcCtD
Zaleplon—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000668	0.0011	CcSEcCtD
Zaleplon—Hyperglycaemia—Memantine—Alzheimer's disease	0.000667	0.0011	CcSEcCtD
Zaleplon—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000666	0.0011	CcSEcCtD
Zaleplon—Pneumonia—Memantine—Alzheimer's disease	0.000663	0.0011	CcSEcCtD
Zaleplon—Malaise—Galantamine—Alzheimer's disease	0.00066	0.00109	CcSEcCtD
Zaleplon—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00066	0.00109	CcSEcCtD
Zaleplon—Weight increased—Rivastigmine—Alzheimer's disease	0.000658	0.00109	CcSEcCtD
Zaleplon—Vertigo—Galantamine—Alzheimer's disease	0.000658	0.00109	CcSEcCtD
Zaleplon—Depression—Memantine—Alzheimer's disease	0.000657	0.00109	CcSEcCtD
Zaleplon—Syncope—Galantamine—Alzheimer's disease	0.000656	0.00108	CcSEcCtD
Zaleplon—Weight decreased—Rivastigmine—Alzheimer's disease	0.000654	0.00108	CcSEcCtD
Zaleplon—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000652	0.00108	CcSEcCtD
Zaleplon—Pneumonia—Rivastigmine—Alzheimer's disease	0.000649	0.00107	CcSEcCtD
Zaleplon—Hallucination—Donepezil—Alzheimer's disease	0.000648	0.00107	CcSEcCtD
Zaleplon—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000648	0.00107	CcSEcCtD
Zaleplon—Palpitations—Galantamine—Alzheimer's disease	0.000647	0.00107	CcSEcCtD
Zaleplon—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000646	0.00107	CcSEcCtD
Zaleplon—Loss of consciousness—Galantamine—Alzheimer's disease	0.000643	0.00106	CcSEcCtD
Zaleplon—Depression—Rivastigmine—Alzheimer's disease	0.000643	0.00106	CcSEcCtD
Zaleplon—Oedema peripheral—Donepezil—Alzheimer's disease	0.000642	0.00106	CcSEcCtD
Zaleplon—Conjunctivitis—Memantine—Alzheimer's disease	0.000641	0.00106	CcSEcCtD
Zaleplon—CYP3A4—nervous system—Alzheimer's disease	0.000636	0.00852	CbGeAlD
Zaleplon—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000632	0.00104	CcSEcCtD
Zaleplon—Hypertension—Galantamine—Alzheimer's disease	0.000632	0.00104	CcSEcCtD
Zaleplon—Haematuria—Memantine—Alzheimer's disease	0.000628	0.00104	CcSEcCtD
Zaleplon—Visual impairment—Donepezil—Alzheimer's disease	0.000628	0.00104	CcSEcCtD
Zaleplon—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000627	0.00104	CcSEcCtD
Zaleplon—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000623	0.00103	CcSEcCtD
Zaleplon—Chest pain—Galantamine—Alzheimer's disease	0.000623	0.00103	CcSEcCtD
Zaleplon—Arthralgia—Galantamine—Alzheimer's disease	0.000623	0.00103	CcSEcCtD
Zaleplon—Myalgia—Galantamine—Alzheimer's disease	0.000623	0.00103	CcSEcCtD
Zaleplon—Epistaxis—Memantine—Alzheimer's disease	0.000622	0.00103	CcSEcCtD
Zaleplon—Anxiety—Galantamine—Alzheimer's disease	0.000621	0.00103	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000619	0.00102	CcSEcCtD
Zaleplon—Sweating—Rivastigmine—Alzheimer's disease	0.000618	0.00102	CcSEcCtD
Zaleplon—Discomfort—Galantamine—Alzheimer's disease	0.000616	0.00102	CcSEcCtD
Zaleplon—Haematuria—Rivastigmine—Alzheimer's disease	0.000615	0.00102	CcSEcCtD
Zaleplon—CYP3A4—central nervous system—Alzheimer's disease	0.000612	0.0082	CbGeAlD
Zaleplon—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00061	0.00101	CcSEcCtD
Zaleplon—Dry mouth—Galantamine—Alzheimer's disease	0.000609	0.00101	CcSEcCtD
Zaleplon—Epistaxis—Rivastigmine—Alzheimer's disease	0.000608	0.001	CcSEcCtD
Zaleplon—Tinnitus—Donepezil—Alzheimer's disease	0.000608	0.001	CcSEcCtD
Zaleplon—Confusional state—Galantamine—Alzheimer's disease	0.000602	0.000995	CcSEcCtD
Zaleplon—Hallucination—Memantine—Alzheimer's disease	0.000589	0.000973	CcSEcCtD
Zaleplon—Hypoaesthesia—Memantine—Alzheimer's disease	0.000589	0.000973	CcSEcCtD
Zaleplon—Shock—Galantamine—Alzheimer's disease	0.000588	0.000971	CcSEcCtD
Zaleplon—Nervous system disorder—Galantamine—Alzheimer's disease	0.000586	0.000968	CcSEcCtD
Zaleplon—Chills—Donepezil—Alzheimer's disease	0.000585	0.000966	CcSEcCtD
Zaleplon—Tachycardia—Galantamine—Alzheimer's disease	0.000583	0.000963	CcSEcCtD
Zaleplon—Oedema peripheral—Memantine—Alzheimer's disease	0.000583	0.000963	CcSEcCtD
Zaleplon—Skin disorder—Galantamine—Alzheimer's disease	0.00058	0.000959	CcSEcCtD
Zaleplon—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000577	0.000954	CcSEcCtD
Zaleplon—Hallucination—Rivastigmine—Alzheimer's disease	0.000576	0.000952	CcSEcCtD
Zaleplon—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000576	0.000952	CcSEcCtD
Zaleplon—Alopecia—Donepezil—Alzheimer's disease	0.000576	0.000951	CcSEcCtD
Zaleplon—Mental disorder—Donepezil—Alzheimer's disease	0.000571	0.000943	CcSEcCtD
Zaleplon—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00057	0.000942	CcSEcCtD
Zaleplon—Visual impairment—Memantine—Alzheimer's disease	0.00057	0.000942	CcSEcCtD
Zaleplon—Anorexia—Galantamine—Alzheimer's disease	0.000569	0.000941	CcSEcCtD
Zaleplon—Malnutrition—Donepezil—Alzheimer's disease	0.000567	0.000937	CcSEcCtD
Zaleplon—Flatulence—Donepezil—Alzheimer's disease	0.000559	0.000924	CcSEcCtD
Zaleplon—Hypotension—Galantamine—Alzheimer's disease	0.000558	0.000922	CcSEcCtD
Zaleplon—Visual impairment—Rivastigmine—Alzheimer's disease	0.000558	0.000922	CcSEcCtD
Zaleplon—Tension—Donepezil—Alzheimer's disease	0.000557	0.00092	CcSEcCtD
Zaleplon—Dysgeusia—Donepezil—Alzheimer's disease	0.000555	0.000918	CcSEcCtD
Zaleplon—Eye disorder—Memantine—Alzheimer's disease	0.000553	0.000914	CcSEcCtD
Zaleplon—Tinnitus—Memantine—Alzheimer's disease	0.000552	0.000912	CcSEcCtD
Zaleplon—Nervousness—Donepezil—Alzheimer's disease	0.000551	0.00091	CcSEcCtD
Zaleplon—Back pain—Donepezil—Alzheimer's disease	0.000549	0.000907	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000544	0.000899	CcSEcCtD
Zaleplon—Eye disorder—Rivastigmine—Alzheimer's disease	0.000541	0.000894	CcSEcCtD
Zaleplon—Insomnia—Galantamine—Alzheimer's disease	0.00054	0.000893	CcSEcCtD
Zaleplon—Tinnitus—Rivastigmine—Alzheimer's disease	0.00054	0.000892	CcSEcCtD
Zaleplon—Paraesthesia—Galantamine—Alzheimer's disease	0.000536	0.000886	CcSEcCtD
Zaleplon—Immune system disorder—Memantine—Alzheimer's disease	0.000534	0.000883	CcSEcCtD
Zaleplon—Tremor—Donepezil—Alzheimer's disease	0.000531	0.000878	CcSEcCtD
Zaleplon—Somnolence—Galantamine—Alzheimer's disease	0.000531	0.000878	CcSEcCtD
Zaleplon—Chills—Memantine—Alzheimer's disease	0.000531	0.000877	CcSEcCtD
Zaleplon—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000526	0.00087	CcSEcCtD
Zaleplon—Dyspepsia—Galantamine—Alzheimer's disease	0.000526	0.000869	CcSEcCtD
Zaleplon—Anaemia—Donepezil—Alzheimer's disease	0.000524	0.000866	CcSEcCtD
Zaleplon—Alopecia—Memantine—Alzheimer's disease	0.000523	0.000864	CcSEcCtD
Zaleplon—Agitation—Donepezil—Alzheimer's disease	0.000521	0.000861	CcSEcCtD
Zaleplon—Chills—Rivastigmine—Alzheimer's disease	0.000519	0.000858	CcSEcCtD
Zaleplon—Decreased appetite—Galantamine—Alzheimer's disease	0.000519	0.000858	CcSEcCtD
Zaleplon—Mental disorder—Memantine—Alzheimer's disease	0.000518	0.000857	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000516	0.000852	CcSEcCtD
Zaleplon—Malnutrition—Memantine—Alzheimer's disease	0.000515	0.000851	CcSEcCtD
Zaleplon—Malaise—Donepezil—Alzheimer's disease	0.000512	0.000845	CcSEcCtD
Zaleplon—Alopecia—Rivastigmine—Alzheimer's disease	0.000511	0.000845	CcSEcCtD
Zaleplon—Constipation—Galantamine—Alzheimer's disease	0.000511	0.000844	CcSEcCtD
Zaleplon—Vertigo—Donepezil—Alzheimer's disease	0.00051	0.000842	CcSEcCtD
Zaleplon—Syncope—Donepezil—Alzheimer's disease	0.000509	0.000841	CcSEcCtD
Zaleplon—Flatulence—Memantine—Alzheimer's disease	0.000508	0.000839	CcSEcCtD
Zaleplon—Mental disorder—Rivastigmine—Alzheimer's disease	0.000507	0.000838	CcSEcCtD
Zaleplon—Tension—Memantine—Alzheimer's disease	0.000505	0.000835	CcSEcCtD
Zaleplon—Dysgeusia—Memantine—Alzheimer's disease	0.000504	0.000833	CcSEcCtD
Zaleplon—Malnutrition—Rivastigmine—Alzheimer's disease	0.000504	0.000833	CcSEcCtD
Zaleplon—Nervousness—Memantine—Alzheimer's disease	0.0005	0.000827	CcSEcCtD
Zaleplon—Loss of consciousness—Donepezil—Alzheimer's disease	0.000499	0.000824	CcSEcCtD
Zaleplon—Back pain—Memantine—Alzheimer's disease	0.000498	0.000823	CcSEcCtD
Zaleplon—Flatulence—Rivastigmine—Alzheimer's disease	0.000496	0.00082	CcSEcCtD
Zaleplon—Tension—Rivastigmine—Alzheimer's disease	0.000494	0.000817	CcSEcCtD
Zaleplon—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000493	0.000815	CcSEcCtD
Zaleplon—Feeling abnormal—Galantamine—Alzheimer's disease	0.000492	0.000813	CcSEcCtD
Zaleplon—Hypertension—Donepezil—Alzheimer's disease	0.00049	0.000809	CcSEcCtD
Zaleplon—Nervousness—Rivastigmine—Alzheimer's disease	0.000489	0.000809	CcSEcCtD
Zaleplon—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000488	0.000807	CcSEcCtD
Zaleplon—Back pain—Rivastigmine—Alzheimer's disease	0.000487	0.000805	CcSEcCtD
Zaleplon—Chest pain—Donepezil—Alzheimer's disease	0.000483	0.000798	CcSEcCtD
Zaleplon—Arthralgia—Donepezil—Alzheimer's disease	0.000483	0.000798	CcSEcCtD
Zaleplon—Myalgia—Donepezil—Alzheimer's disease	0.000483	0.000798	CcSEcCtD
Zaleplon—Tremor—Memantine—Alzheimer's disease	0.000483	0.000797	CcSEcCtD
Zaleplon—Anxiety—Donepezil—Alzheimer's disease	0.000481	0.000795	CcSEcCtD
Zaleplon—Ill-defined disorder—Memantine—Alzheimer's disease	0.000478	0.00079	CcSEcCtD
Zaleplon—Discomfort—Donepezil—Alzheimer's disease	0.000477	0.000788	CcSEcCtD
Zaleplon—Anaemia—Memantine—Alzheimer's disease	0.000476	0.000787	CcSEcCtD
Zaleplon—Agitation—Memantine—Alzheimer's disease	0.000473	0.000782	CcSEcCtD
Zaleplon—Dry mouth—Donepezil—Alzheimer's disease	0.000472	0.00078	CcSEcCtD
Zaleplon—Abdominal pain—Galantamine—Alzheimer's disease	0.000472	0.00078	CcSEcCtD
Zaleplon—Body temperature increased—Galantamine—Alzheimer's disease	0.000472	0.00078	CcSEcCtD
Zaleplon—Tremor—Rivastigmine—Alzheimer's disease	0.000472	0.00078	CcSEcCtD
Zaleplon—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000468	0.000772	CcSEcCtD
Zaleplon—Confusional state—Donepezil—Alzheimer's disease	0.000467	0.000771	CcSEcCtD
Zaleplon—Anaemia—Rivastigmine—Alzheimer's disease	0.000466	0.00077	CcSEcCtD
Zaleplon—Malaise—Memantine—Alzheimer's disease	0.000464	0.000767	CcSEcCtD
Zaleplon—Agitation—Rivastigmine—Alzheimer's disease	0.000463	0.000765	CcSEcCtD
Zaleplon—Oedema—Donepezil—Alzheimer's disease	0.000463	0.000765	CcSEcCtD
Zaleplon—Vertigo—Memantine—Alzheimer's disease	0.000463	0.000765	CcSEcCtD
Zaleplon—Syncope—Memantine—Alzheimer's disease	0.000462	0.000763	CcSEcCtD
Zaleplon—Shock—Donepezil—Alzheimer's disease	0.000455	0.000753	CcSEcCtD
Zaleplon—Palpitations—Memantine—Alzheimer's disease	0.000455	0.000752	CcSEcCtD
Zaleplon—Malaise—Rivastigmine—Alzheimer's disease	0.000454	0.000751	CcSEcCtD
Zaleplon—Nervous system disorder—Donepezil—Alzheimer's disease	0.000454	0.00075	CcSEcCtD
Zaleplon—Vertigo—Rivastigmine—Alzheimer's disease	0.000453	0.000748	CcSEcCtD
Zaleplon—Loss of consciousness—Memantine—Alzheimer's disease	0.000453	0.000748	CcSEcCtD
Zaleplon—Syncope—Rivastigmine—Alzheimer's disease	0.000452	0.000747	CcSEcCtD
Zaleplon—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000448	0.00074	CcSEcCtD
Zaleplon—Palpitations—Rivastigmine—Alzheimer's disease	0.000445	0.000736	CcSEcCtD
Zaleplon—Hypertension—Memantine—Alzheimer's disease	0.000445	0.000735	CcSEcCtD
Zaleplon—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000443	0.000732	CcSEcCtD
Zaleplon—Anorexia—Donepezil—Alzheimer's disease	0.000441	0.000729	CcSEcCtD
Zaleplon—Myalgia—Memantine—Alzheimer's disease	0.000438	0.000725	CcSEcCtD
Zaleplon—Arthralgia—Memantine—Alzheimer's disease	0.000438	0.000725	CcSEcCtD
Zaleplon—Chest pain—Memantine—Alzheimer's disease	0.000438	0.000725	CcSEcCtD
Zaleplon—Anxiety—Memantine—Alzheimer's disease	0.000437	0.000722	CcSEcCtD
Zaleplon—Hypertension—Rivastigmine—Alzheimer's disease	0.000435	0.000719	CcSEcCtD
Zaleplon—Discomfort—Memantine—Alzheimer's disease	0.000433	0.000716	CcSEcCtD
Zaleplon—Hypotension—Donepezil—Alzheimer's disease	0.000433	0.000715	CcSEcCtD
Zaleplon—Myalgia—Rivastigmine—Alzheimer's disease	0.000429	0.000709	CcSEcCtD
Zaleplon—Chest pain—Rivastigmine—Alzheimer's disease	0.000429	0.000709	CcSEcCtD
Zaleplon—Arthralgia—Rivastigmine—Alzheimer's disease	0.000429	0.000709	CcSEcCtD
Zaleplon—Dry mouth—Memantine—Alzheimer's disease	0.000429	0.000709	CcSEcCtD
Zaleplon—Asthenia—Galantamine—Alzheimer's disease	0.000429	0.000708	CcSEcCtD
Zaleplon—Anxiety—Rivastigmine—Alzheimer's disease	0.000427	0.000706	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000426	0.000704	CcSEcCtD
Zaleplon—Confusional state—Memantine—Alzheimer's disease	0.000424	0.0007	CcSEcCtD
Zaleplon—Discomfort—Rivastigmine—Alzheimer's disease	0.000424	0.0007	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000422	0.000697	CcSEcCtD
Zaleplon—Oedema—Memantine—Alzheimer's disease	0.00042	0.000695	CcSEcCtD
Zaleplon—Dry mouth—Rivastigmine—Alzheimer's disease	0.00042	0.000693	CcSEcCtD
Zaleplon—Insomnia—Donepezil—Alzheimer's disease	0.000419	0.000692	CcSEcCtD
Zaleplon—Paraesthesia—Donepezil—Alzheimer's disease	0.000416	0.000687	CcSEcCtD
Zaleplon—Confusional state—Rivastigmine—Alzheimer's disease	0.000415	0.000685	CcSEcCtD
Zaleplon—Shock—Memantine—Alzheimer's disease	0.000414	0.000683	CcSEcCtD
Zaleplon—Dyspnoea—Donepezil—Alzheimer's disease	0.000413	0.000682	CcSEcCtD
Zaleplon—Nervous system disorder—Memantine—Alzheimer's disease	0.000412	0.000681	CcSEcCtD
Zaleplon—Somnolence—Donepezil—Alzheimer's disease	0.000412	0.00068	CcSEcCtD
Zaleplon—Oedema—Rivastigmine—Alzheimer's disease	0.000411	0.000679	CcSEcCtD
Zaleplon—Tachycardia—Memantine—Alzheimer's disease	0.00041	0.000678	CcSEcCtD
Zaleplon—Skin disorder—Memantine—Alzheimer's disease	0.000408	0.000675	CcSEcCtD
Zaleplon—Dyspepsia—Donepezil—Alzheimer's disease	0.000408	0.000673	CcSEcCtD
Zaleplon—Hyperhidrosis—Memantine—Alzheimer's disease	0.000406	0.000671	CcSEcCtD
Zaleplon—Shock—Rivastigmine—Alzheimer's disease	0.000405	0.000669	CcSEcCtD
Zaleplon—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000403	0.000666	CcSEcCtD
Zaleplon—Decreased appetite—Donepezil—Alzheimer's disease	0.000402	0.000665	CcSEcCtD
Zaleplon—Tachycardia—Rivastigmine—Alzheimer's disease	0.000401	0.000663	CcSEcCtD
Zaleplon—Anorexia—Memantine—Alzheimer's disease	0.000401	0.000662	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.0004	0.00066	CcSEcCtD
Zaleplon—Skin disorder—Rivastigmine—Alzheimer's disease	0.000399	0.00066	CcSEcCtD
Zaleplon—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000398	0.000657	CcSEcCtD
Zaleplon—Pain—Donepezil—Alzheimer's disease	0.000396	0.000654	CcSEcCtD
Zaleplon—Constipation—Donepezil—Alzheimer's disease	0.000396	0.000654	CcSEcCtD
Zaleplon—Dizziness—Galantamine—Alzheimer's disease	0.000395	0.000653	CcSEcCtD
Zaleplon—Hypotension—Memantine—Alzheimer's disease	0.000393	0.000649	CcSEcCtD
Zaleplon—Anorexia—Rivastigmine—Alzheimer's disease	0.000392	0.000648	CcSEcCtD
Zaleplon—Hypotension—Rivastigmine—Alzheimer's disease	0.000384	0.000635	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000383	0.000633	CcSEcCtD
Zaleplon—Feeling abnormal—Donepezil—Alzheimer's disease	0.000382	0.00063	CcSEcCtD
Zaleplon—Insomnia—Memantine—Alzheimer's disease	0.00038	0.000628	CcSEcCtD
Zaleplon—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000379	0.000626	CcSEcCtD
Zaleplon—Paraesthesia—Memantine—Alzheimer's disease	0.000377	0.000624	CcSEcCtD
Zaleplon—Rash—Galantamine—Alzheimer's disease	0.000377	0.000622	CcSEcCtD
Zaleplon—Dermatitis—Galantamine—Alzheimer's disease	0.000376	0.000622	CcSEcCtD
Zaleplon—Dyspnoea—Memantine—Alzheimer's disease	0.000375	0.000619	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000375	0.000619	CcSEcCtD
Zaleplon—Headache—Galantamine—Alzheimer's disease	0.000374	0.000618	CcSEcCtD
Zaleplon—Somnolence—Memantine—Alzheimer's disease	0.000374	0.000617	CcSEcCtD
Zaleplon—Insomnia—Rivastigmine—Alzheimer's disease	0.000372	0.000615	CcSEcCtD
Zaleplon—Dyspepsia—Memantine—Alzheimer's disease	0.00037	0.000611	CcSEcCtD
Zaleplon—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000369	0.00061	CcSEcCtD
Zaleplon—Urticaria—Donepezil—Alzheimer's disease	0.000368	0.000608	CcSEcCtD
Zaleplon—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000367	0.000606	CcSEcCtD
Zaleplon—Abdominal pain—Donepezil—Alzheimer's disease	0.000366	0.000605	CcSEcCtD
Zaleplon—Body temperature increased—Donepezil—Alzheimer's disease	0.000366	0.000605	CcSEcCtD
Zaleplon—Somnolence—Rivastigmine—Alzheimer's disease	0.000366	0.000604	CcSEcCtD
Zaleplon—Decreased appetite—Memantine—Alzheimer's disease	0.000365	0.000604	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000363	0.0006	CcSEcCtD
Zaleplon—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000362	0.000598	CcSEcCtD
Zaleplon—Pain—Memantine—Alzheimer's disease	0.000359	0.000594	CcSEcCtD
Zaleplon—Constipation—Memantine—Alzheimer's disease	0.000359	0.000594	CcSEcCtD
Zaleplon—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000357	0.000591	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000355	0.000587	CcSEcCtD
Zaleplon—Nausea—Galantamine—Alzheimer's disease	0.000355	0.000586	CcSEcCtD
Zaleplon—Constipation—Rivastigmine—Alzheimer's disease	0.000352	0.000581	CcSEcCtD
Zaleplon—Pain—Rivastigmine—Alzheimer's disease	0.000352	0.000581	CcSEcCtD
Zaleplon—Feeling abnormal—Memantine—Alzheimer's disease	0.000346	0.000572	CcSEcCtD
Zaleplon—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000344	0.000568	CcSEcCtD
Zaleplon—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000339	0.00056	CcSEcCtD
Zaleplon—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000336	0.000556	CcSEcCtD
Zaleplon—Urticaria—Memantine—Alzheimer's disease	0.000334	0.000552	CcSEcCtD
Zaleplon—Abdominal pain—Memantine—Alzheimer's disease	0.000332	0.000549	CcSEcCtD
Zaleplon—Body temperature increased—Memantine—Alzheimer's disease	0.000332	0.000549	CcSEcCtD
Zaleplon—Asthenia—Donepezil—Alzheimer's disease	0.000332	0.000549	CcSEcCtD
Zaleplon—Pruritus—Donepezil—Alzheimer's disease	0.000328	0.000541	CcSEcCtD
Zaleplon—Urticaria—Rivastigmine—Alzheimer's disease	0.000327	0.00054	CcSEcCtD
Zaleplon—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000325	0.000537	CcSEcCtD
Zaleplon—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000325	0.000537	CcSEcCtD
Zaleplon—Dizziness—Donepezil—Alzheimer's disease	0.000306	0.000506	CcSEcCtD
Zaleplon—Asthenia—Memantine—Alzheimer's disease	0.000302	0.000498	CcSEcCtD
Zaleplon—Pruritus—Memantine—Alzheimer's disease	0.000297	0.000491	CcSEcCtD
Zaleplon—Asthenia—Rivastigmine—Alzheimer's disease	0.000295	0.000488	CcSEcCtD
Zaleplon—Rash—Donepezil—Alzheimer's disease	0.000292	0.000482	CcSEcCtD
Zaleplon—Dermatitis—Donepezil—Alzheimer's disease	0.000292	0.000482	CcSEcCtD
Zaleplon—Pruritus—Rivastigmine—Alzheimer's disease	0.000291	0.000481	CcSEcCtD
Zaleplon—Headache—Donepezil—Alzheimer's disease	0.00029	0.000479	CcSEcCtD
Zaleplon—Dizziness—Memantine—Alzheimer's disease	0.000278	0.000459	CcSEcCtD
Zaleplon—Nausea—Donepezil—Alzheimer's disease	0.000275	0.000454	CcSEcCtD
Zaleplon—Dizziness—Rivastigmine—Alzheimer's disease	0.000272	0.000449	CcSEcCtD
Zaleplon—Rash—Memantine—Alzheimer's disease	0.000265	0.000438	CcSEcCtD
Zaleplon—Dermatitis—Memantine—Alzheimer's disease	0.000265	0.000438	CcSEcCtD
Zaleplon—Headache—Memantine—Alzheimer's disease	0.000263	0.000435	CcSEcCtD
Zaleplon—Rash—Rivastigmine—Alzheimer's disease	0.000259	0.000428	CcSEcCtD
Zaleplon—Dermatitis—Rivastigmine—Alzheimer's disease	0.000259	0.000428	CcSEcCtD
Zaleplon—Headache—Rivastigmine—Alzheimer's disease	0.000258	0.000426	CcSEcCtD
Zaleplon—Nausea—Memantine—Alzheimer's disease	0.00025	0.000413	CcSEcCtD
Zaleplon—Nausea—Rivastigmine—Alzheimer's disease	0.000244	0.000404	CcSEcCtD
Zaleplon—GABRB3—Neuronal System—DLG4—Alzheimer's disease	0.000161	0.00128	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CHRNA4—Alzheimer's disease	0.000161	0.00127	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000161	0.00127	CbGpPWpGaD
Zaleplon—AOX1—Disease—SNCA—Alzheimer's disease	0.000161	0.00127	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00016	0.00127	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000159	0.00126	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—GRIN2B—Alzheimer's disease	0.000159	0.00126	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—DLG4—Alzheimer's disease	0.000159	0.00125	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000158	0.00125	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—GRIN2B—Alzheimer's disease	0.000158	0.00125	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—PLCB1—Alzheimer's disease	0.000157	0.00124	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000156	0.00123	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—PLCB1—Alzheimer's disease	0.000156	0.00123	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—GRIN2B—Alzheimer's disease	0.000155	0.00123	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000154	0.00122	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000154	0.00121	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—PLCB1—Alzheimer's disease	0.000153	0.00121	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000152	0.0012	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000152	0.0012	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000151	0.00119	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—PTGS1—Alzheimer's disease	0.000149	0.00118	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000149	0.00118	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.000149	0.00118	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000148	0.00117	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000148	0.00117	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP2D6—Alzheimer's disease	0.000147	0.00116	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—GSK3B—Alzheimer's disease	0.000146	0.00116	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000146	0.00116	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000146	0.00115	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—CREB1—Alzheimer's disease	0.000145	0.00115	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000145	0.00114	CbGpPWpGaD
Zaleplon—AOX1—Disease—PSENEN—Alzheimer's disease	0.000143	0.00113	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—BCHE—Alzheimer's disease	0.000142	0.00112	CbGpPWpGaD
Zaleplon—AOX1—Disease—APH1A—Alzheimer's disease	0.000141	0.00112	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.00014	0.00111	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—DLG4—Alzheimer's disease	0.000139	0.0011	CbGpPWpGaD
Zaleplon—AOX1—Disease—NCSTN—Alzheimer's disease	0.000137	0.00109	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—GRIN2B—Alzheimer's disease	0.000135	0.00107	CbGpPWpGaD
Zaleplon—AOX1—Disease—LRP1—Alzheimer's disease	0.000134	0.00106	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—PLCB1—Alzheimer's disease	0.000134	0.00106	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000131	0.00104	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000131	0.00103	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.00013	0.00103	CbGpPWpGaD
Zaleplon—AOX1—Disease—TPI1—Alzheimer's disease	0.000129	0.00102	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000129	0.00102	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000128	0.00101	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000128	0.00101	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000127	0.00101	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000126	0.000996	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—PRKCG—Alzheimer's disease	0.000124	0.00098	CbGpPWpGaD
Zaleplon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000124	0.000979	CbGpPWpGaD
Zaleplon—AOX1—Disease—EIF2AK2—Alzheimer's disease	0.000122	0.000962	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.00012	0.000947	CbGpPWpGaD
Zaleplon—AOX1—Disease—GAPDH—Alzheimer's disease	0.000119	0.000944	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000118	0.000934	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000117	0.000928	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—DHCR24—Alzheimer's disease	0.000117	0.000927	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000117	0.000924	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—PRKCG—Alzheimer's disease	0.000116	0.000919	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—PRKCG—Alzheimer's disease	0.000115	0.000913	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000115	0.000911	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—PRKCG—Alzheimer's disease	0.000113	0.000896	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000112	0.000888	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000112	0.000885	CbGpPWpGaD
Zaleplon—AOX1—Disease—PSEN2—Alzheimer's disease	0.000112	0.000883	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000112	0.000882	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.00011	0.000866	CbGpPWpGaD
Zaleplon—AOX1—Disease—CST3—Alzheimer's disease	0.000109	0.000864	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CHAT—Alzheimer's disease	0.000108	0.000857	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—TPI1—Alzheimer's disease	0.000108	0.000857	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—CASP3—Alzheimer's disease	0.000107	0.000849	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CALM1—Alzheimer's disease	0.000107	0.000848	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000107	0.000847	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—MAOB—Alzheimer's disease	0.000104	0.000822	CbGpPWpGaD
Zaleplon—AOX1—Disease—IAPP—Alzheimer's disease	0.000102	0.000808	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000101	0.000796	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CALM1—Alzheimer's disease	0.000101	0.000795	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.0001	0.000794	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GAPDH—Alzheimer's disease	0.0001	0.000791	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CALM1—Alzheimer's disease	9.99e-05	0.00079	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—TF—Alzheimer's disease	9.98e-05	0.000789	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CA4—Alzheimer's disease	9.97e-05	0.000788	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—PRKCG—Alzheimer's disease	9.91e-05	0.000783	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—MAPK8—Alzheimer's disease	9.87e-05	0.000781	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—CALM1—Alzheimer's disease	9.81e-05	0.000775	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—TF—Alzheimer's disease	9.8e-05	0.000775	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—A2M—Alzheimer's disease	9.66e-05	0.000764	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	9.58e-05	0.000757	CbGpPWpGaD
Zaleplon—AOX1—Disease—ENO1—Alzheimer's disease	9.4e-05	0.000744	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GAPDHS—Alzheimer's disease	9.37e-05	0.000741	CbGpPWpGaD
Zaleplon—AOX1—Disease—PPP3CA—Alzheimer's disease	9.36e-05	0.00074	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CREB1—Alzheimer's disease	9.18e-05	0.000726	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	9.17e-05	0.000725	CbGpPWpGaD
Zaleplon—AOX1—Disease—GAB2—Alzheimer's disease	8.97e-05	0.000709	CbGpPWpGaD
Zaleplon—AOX1—Disease—GSK3A—Alzheimer's disease	8.89e-05	0.000703	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ATP5A1—Alzheimer's disease	8.88e-05	0.000702	CbGpPWpGaD
Zaleplon—AOX1—Disease—APP—Alzheimer's disease	8.74e-05	0.000691	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	8.67e-05	0.000685	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	8.65e-05	0.000684	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CREB1—Alzheimer's disease	8.6e-05	0.00068	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CALM1—Alzheimer's disease	8.57e-05	0.000678	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—TF—Alzheimer's disease	8.56e-05	0.000677	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CREB1—Alzheimer's disease	8.55e-05	0.000676	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLD3—Alzheimer's disease	8.47e-05	0.00067	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—DHCR24—Alzheimer's disease	8.47e-05	0.00067	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ACHE—Alzheimer's disease	8.4e-05	0.000664	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—CREB1—Alzheimer's disease	8.39e-05	0.000664	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—INPP5D—Alzheimer's disease	8.31e-05	0.000657	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HSD17B10—Alzheimer's disease	8.12e-05	0.000642	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ENO1—Alzheimer's disease	7.87e-05	0.000623	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS1—Alzheimer's disease	7.87e-05	0.000623	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP46A1—Alzheimer's disease	7.82e-05	0.000618	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2D6—Alzheimer's disease	7.72e-05	0.000611	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ND1—Alzheimer's disease	7.55e-05	0.000597	CbGpPWpGaD
Zaleplon—AOX1—Disease—ADAM10—Alzheimer's disease	7.52e-05	0.000594	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	7.49e-05	0.000592	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	7.34e-05	0.00058	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CREB1—Alzheimer's disease	7.34e-05	0.00058	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—BCHE—Alzheimer's disease	7.32e-05	0.000579	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CA4—Alzheimer's disease	7.2e-05	0.00057	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	7.02e-05	0.000555	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.98e-05	0.000552	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	6.95e-05	0.000549	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PLCB1—Alzheimer's disease	6.91e-05	0.000546	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.85e-05	0.000542	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	6.81e-05	0.000539	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	6.77e-05	0.000536	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	6.72e-05	0.000531	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ABCA1—Alzheimer's disease	6.7e-05	0.000529	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	6.42e-05	0.000508	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	6.29e-05	0.000497	CbGpPWpGaD
Zaleplon—AOX1—Disease—LPL—Alzheimer's disease	6.27e-05	0.000496	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLD3—Alzheimer's disease	6.13e-05	0.000484	CbGpPWpGaD
Zaleplon—AOX1—Disease—PRKCG—Alzheimer's disease	6.1e-05	0.000482	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.99e-05	0.000474	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	5.87e-05	0.000464	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—AKT1—Alzheimer's disease	5.82e-05	0.00046	CbGpPWpGaD
Zaleplon—AOX1—Disease—CCR5—Alzheimer's disease	5.78e-05	0.000457	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARGC1A—Alzheimer's disease	5.77e-05	0.000456	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMOX1—Alzheimer's disease	5.74e-05	0.000454	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	5.65e-05	0.000447	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTHFR—Alzheimer's disease	5.65e-05	0.000447	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ND1—Alzheimer's disease	5.46e-05	0.000432	CbGpPWpGaD
Zaleplon—AOX1—Disease—CALM1—Alzheimer's disease	5.28e-05	0.000417	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOE—Alzheimer's disease	5.26e-05	0.000416	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—LPL—Alzheimer's disease	5.25e-05	0.000415	CbGpPWpGaD
Zaleplon—AOX1—Disease—CAV1—Alzheimer's disease	5.21e-05	0.000412	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	5.08e-05	0.000401	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS2—Alzheimer's disease	4.9e-05	0.000387	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CHAT—Alzheimer's disease	4.87e-05	0.000385	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TPI1—Alzheimer's disease	4.87e-05	0.000385	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOTCH1—Alzheimer's disease	4.85e-05	0.000384	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—MTHFR—Alzheimer's disease	4.73e-05	0.000374	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MAOB—Alzheimer's disease	4.67e-05	0.000369	CbGpPWpGaD
Zaleplon—AOX1—Disease—GSK3B—Alzheimer's disease	4.55e-05	0.00036	CbGpPWpGaD
Zaleplon—AOX1—Disease—CREB1—Alzheimer's disease	4.52e-05	0.000357	CbGpPWpGaD
Zaleplon—AOX1—Disease—INS—Alzheimer's disease	4.49e-05	0.000355	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GAPDH—Alzheimer's disease	4.49e-05	0.000355	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CALM1—Alzheimer's disease	4.42e-05	0.000349	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOE—Alzheimer's disease	4.4e-05	0.000348	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CAV1—Alzheimer's disease	4.36e-05	0.000345	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—A2M—Alzheimer's disease	4.34e-05	0.000343	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS3—Alzheimer's disease	3.94e-05	0.000312	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.94e-05	0.000311	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARG—Alzheimer's disease	3.84e-05	0.000303	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ACHE—Alzheimer's disease	3.77e-05	0.000298	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—INS—Alzheimer's disease	3.76e-05	0.000298	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	3.73e-05	0.000295	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—Alzheimer's disease	3.6e-05	0.000285	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ENO1—Alzheimer's disease	3.54e-05	0.00028	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	3.54e-05	0.00028	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TPI1—Alzheimer's disease	3.52e-05	0.000278	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CHAT—Alzheimer's disease	3.52e-05	0.000278	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	3.47e-05	0.000274	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MAOB—Alzheimer's disease	3.37e-05	0.000267	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.35e-05	0.000265	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NOS3—Alzheimer's disease	3.3e-05	0.000261	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BCHE—Alzheimer's disease	3.29e-05	0.00026	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	3.25e-05	0.000257	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.15e-05	0.000249	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—A2M—Alzheimer's disease	3.14e-05	0.000248	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	3.1e-05	0.000245	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—Alzheimer's disease	3.02e-05	0.000239	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	3.01e-05	0.000238	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.98e-05	0.000236	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.85e-05	0.000225	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.73e-05	0.000216	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ACHE—Alzheimer's disease	2.73e-05	0.000216	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	2.7e-05	0.000213	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.63e-05	0.000208	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFB1—Alzheimer's disease	2.61e-05	0.000206	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	2.59e-05	0.000205	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	2.58e-05	0.000204	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ENO1—Alzheimer's disease	2.56e-05	0.000202	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	2.56e-05	0.000202	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.54e-05	0.000201	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	2.51e-05	0.000198	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BCHE—Alzheimer's disease	2.38e-05	0.000188	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LPL—Alzheimer's disease	2.36e-05	0.000187	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	2.24e-05	0.000177	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	2.17e-05	0.000172	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	2.12e-05	0.000168	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CALM1—Alzheimer's disease	1.98e-05	0.000157	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOE—Alzheimer's disease	1.98e-05	0.000156	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—Alzheimer's disease	1.96e-05	0.000155	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAV1—Alzheimer's disease	1.96e-05	0.000155	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	1.87e-05	0.000148	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	1.86e-05	0.000147	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—Alzheimer's disease	1.81e-05	0.000143	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARG—Alzheimer's disease	1.72e-05	0.000136	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.71e-05	0.000135	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—INS—Alzheimer's disease	1.69e-05	0.000134	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.64e-05	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.64e-05	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.57e-05	0.000124	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.54e-05	0.000121	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—Alzheimer's disease	1.52e-05	0.00012	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.51e-05	0.000119	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NOS3—Alzheimer's disease	1.48e-05	0.000117	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.46e-05	0.000115	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.43e-05	0.000113	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.43e-05	0.000113	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.42e-05	0.000112	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	1.36e-05	0.000107	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.27e-05	0.0001	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.25e-05	9.91e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.25e-05	9.85e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—INS—Alzheimer's disease	1.22e-05	9.66e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.19e-05	9.4e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.19e-05	9.4e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.17e-05	9.22e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.1e-05	8.74e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.07e-05	8.47e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.04e-05	8.24e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.01e-05	7.99e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	9.8e-06	7.75e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	8.71e-06	6.89e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	8.67e-06	6.86e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LPL—Alzheimer's disease	7.93e-06	6.27e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	7.14e-06	5.65e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—Alzheimer's disease	6.81e-06	5.39e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CALM1—Alzheimer's disease	6.67e-06	5.27e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOE—Alzheimer's disease	6.65e-06	5.26e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAV1—Alzheimer's disease	6.58e-06	5.21e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARG—Alzheimer's disease	5.79e-06	4.58e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—INS—Alzheimer's disease	5.68e-06	4.49e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NOS3—Alzheimer's disease	4.98e-06	3.94e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—Alzheimer's disease	4.92e-06	3.89e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	4.55e-06	3.6e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.29e-06	1.81e-05	CbGpPWpGaD
